Blog

Markets Stage a Mass Sell Off of Gambling Stocks

Published

5 years ago

November 11, 2019

MPs recommended stringent curbs on online casino games worth more than £2bn a year to the industry. This has led to shares in UK gambling firms losing nearly £1.2bn in value. It was recommended by MPs from the cross-party group on gambling-related harm who joined the successful campaign to cut stakes on fixed-odds betting terminals (FOBTs) to £2, that the same limit be applied to web-based slot machine games.

The MPs included the former Conservative party leader Iain Duncan Smith. All of them are understood to be hopeful that they can convince policymakers in No 10 to include tighter controls on gambling firms in the party’s general election manifesto. But the Labour has already backed much tougher regulation of the gambling industry. This indicates that its wings might get clipped regardless of the election result.

Also check out: best new UK casinos at Wisegambler UK

The online-only casino firm 888 was hardest hit. It lost nearly 14% of its value in a day. This slump has cut its market value by £91m. It can concluded that the recommendations will threaten online casinos take from slot-machine players if the proposals are adopted. According to the Gambling Commission, the industry regulator it accounts for more than a third of their income.

The figure would rise from £2bn to £2.9bn if the limits were to include other casino games such as roulette. This game was available at £100 a spin in high street bookmakers. But that was before the government agreed to rein in the machines.It happened after a campaign was started that united politicians and campaigners across the political spectrum. The MPs’ recommendation was responded by the markets. They staged a mass sell-off of gambling stocks on Monday.

Blog

Applications of Automation in Research and Clinical Diagnostics

Published

2 months ago

May 18, 2024

Rosario Farell

Precision counts in the fields of science and medicine. This is particularly true for the basic task of counting and analyzing cells, which is used in both clinical and research settings. The introduction of automatic cell counters, which provide efficiency and accuracy that manual approaches cannot match, has resulted in a notable advancement in this field.

What is Automated Cell Counting?

Automated cell counters are advanced instruments that are made to precisely and swiftly count and examine cells. In contrast to manual counting methods that rely on human vision and a microscope, automated counters use software algorithms and image technology to count and analyze cells. This ensures more accurate findings by expediting the procedure and lowering the possibility of human error.

Type of Automated Cell Counters

There are several types of automated cell counters used in research and clinical diagnostics, each employing different technologies and methods for cell counting. The main types of automated cell counters include:

● Image Cytometers: These devices use optical microscopy to statically image cells, which are frequently labeled to detect certain molecules or provide contrast. Cell counting is aided by the automation of image cytometers made possible by digital cameras.

● Flow Cytometers: Use a regulated flow of suspended cells to align individual cells for analysis. Staining cells with fluorochromes enables visual characterization of the cells and facilitates high-throughput analysis.

● Cell Sorters: Arrange cells according to their electrical properties. Sorting is accomplished by dividing the fluid stream containing the cells into droplets whose electrical charge varies according to the kind of cell and guiding them into various containers.

● Time-Lapse Cytometers: Allow for continuous monitoring of cells in an incubator by employing non-heat-generating light sources, such as LEDs, in conjunction with image cytometry to investigate cellular dynamics without causing damage to living cells.

● Hemocytometers: A qualified technician, an optical microscope, and a gridded slide with known volume wells are used in this manual cell counting approach. Up until the 1950s, hemocytometers were the norm for counting cells.

These various types of automated cell counters provide effective and precise methods for cell counting and analysis, each with unique benefits and uses in clinical and research environments.

Research

Automated cell counters have become indispensable tools in understanding cell behavior. They are used in various research fields, including cancer research, drug discovery, and stem cell therapy.

One of the key benefits in research is the ability to handle large volumes of data. For instance, in drug discovery, automated counters can quickly analyze the effects of thousands of compounds on cell growth and death. This high-throughput capability accelerates the pace of research, allowing scientists to screen potential drugs more efficiently than ever before.

Moreover, automated cell counters offer the precision required to detect subtle changes in cell populations. This is crucial in fields like cancer research, where understanding the behavior of cancer cells can lead to the development of more effective treatments.

Clinical Diagnostics

The impact of automated cell counters extends beyond the research laboratory and into clinical diagnostics. In medical laboratories, these devices play a critical role in routine blood tests, infectious disease diagnostics, and monitoring patient health during treatment.

For example, in a routine complete blood count (CBC), automated cell counters can quickly provide a detailed analysis of different blood cell types. This information is vital for diagnosing conditions such as anemia, infections, and blood cancers. The speed and accuracy of automated counters mean that patients can receive diagnoses and begin treatment more swiftly.

In the context of infectious diseases, automated counters can detect and quantify specific pathogens or immune cells, helping to diagnose infections quickly and accurately. During the COVID-19 pandemic, automated cell counting technologies were instrumental in monitoring virus spread and patients’ immune responses, showcasing their value in crisis situations.

Challenges and Future Directions

The initial cost of these devices can be high, and their operation requires specific technical expertise. Additionally, different types of cells and conditions may require customized counting protocols, necessitating ongoing adjustments and updates to software algorithms.

Looking ahead, ongoing advancements in technology promise to further enhance the capabilities of automated cell counters. The global cell counting market growth is anticipated at a CAGR of 7.5% by 2032. Innovations in imaging technology, artificial intelligence, and machine learning are expected to improve accuracy, speed, and the ability to analyze more complex cell characteristics. As these technologies evolve, automated cell counters will become even more integral to research and diagnostics, opening new avenues for scientific discovery and patient care.